Unresolved clinical aspects and safety hazards of blood derived- EV/MV in stored blood components: From personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena

Seghatchian, 2015, The multifaceted aspects of blood cell-derived micro-particles: an intriguing aspect of my past subject of studies, Transfus Apher Sci, 53, 103, 10.1016/j.transci.2015.10.005 Seghatchian, 2015, Blood cell-derived microvesicles with potential pathogenic roles in therapeutic blood components and specialized diagnostic tools in diseases, Transfus Apher Sci, 53, 108, 10.1016/j.transci.2015.10.007 Poncelet, 2015, Tips and tricks for flow cytometry-based analysis and counting of micro-particles, Transfus Apher Sci, 53, 110, 10.1016/j.transci.2015.10.008 Amiral, 2015, The diagnostic usefulness of captures assays for measuring global/ specific extracellular micro-particles in plasma, Transfus Apher Sci, 53, 127, 10.1016/j.transci.2015.10.009 Burnouf, 2015, An overview of the role of micro-particles/microvesicles in blood components: are they clinically beneficial or harmful?, Transfus Apher Sci, 53, 137, 10.1016/j.transci.2015.10.010 Prudent, 2015, Differences between calcium-stimulated and storage-induced erythrocyte-derived microvesicles, Transfus Apher Sci, 53, 153, 10.1016/j.transci.2015.10.012 Johnson, 2015, Platelet micro-particles in cryopreserved platelets: potential mediators of haemostasis, Transfus Apher Sci, 53, 146, 10.1016/j.transci.2015.10.011 Cognasse, 2015, The role of micro-particles in inflammation and transfusion: a concise review, Transfus Apher Sci, 53, 159, 10.1016/j.transci.2015.10.013 Goubran, 2015, Platelet micro-particles and cancer: an intimate cross talk, Transfus Apher Sci, 53, 168, 10.1016/j.transci.2015.10.014 Lin, 2015, Platelet-derived micro-particles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing micro-particles in vitro, Transfus Apher Sci, 53, 246, 10.1016/j.transci.2015.10.002 Gardiner, 2015, Extracellular vesicles, tissue factor, cancer and thrombosis discussion themes of the ISEV 2014 Educational Day, J Extracell Vesicles, 4, 26901, 10.3402/jev.v4.26901 Goubran, 2015, Platelet micro-particles: a sensitive physiological” fine tuning” balancing factor in health and disease, Transfus Apher Sci, 52, 12, 10.1016/j.transci.2014.12.015 Krailadsiri, 1997, Annexin V, a new marker of platelet storage lesion: correlation with dMPV, Transfus Sci, 18, 223, 10.1016/S0955-3886(97)00013-1 Seghatchian, 2007, A new platelet storage lesion index based on paired samples, without and with EDTA and cell counting: comparison of three types of leukoreduced preparations, Transfus Apher Sci, 35, 283, 10.1016/j.transci.2006.10.003 Vasconcelos, 2005, The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile, Transfus Apher Sci, 32, 221, 10.1016/j.transci.2004.10.013 Krailadsiri, 1997, Microvesicles in blood components: laboratory and clinical aspects, Art Bode Clin Appl Thromb Hem, 3, 86, 10.1177/107602969700300203 Bessos, 1992, Glycoprotein-IB and glycoprotein-IIB/IIIA in the quality assessment of platelet concentrates during storage, Blood Coagul Fibrinolysis, 3, 633, 10.1097/00001721-199210000-00018 Seghatchian, 1978, A new approach to the determination of coagulation factors using chromogenic substrates, Med Lab Sci, 35, 343 Salunkhe, 2015, Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands, Transfus Apher Sci, 52, 19, 10.1016/j.transci.2014.12.016 Prudent, 2014, Proteome changes in platelets after pathogen inactivation – an interlaboratory consensus, Transfus Med Rev, 28, 72, 10.1016/j.tmrv.2014.02.002 Seghatchian, 2015, Highlights of the role of PMP in health & disease & advancements in PRT and quality in transfusion establishments, Transfus Apher Sci, 52, 10, 10.1016/j.transci.2014.12.014 de Sousa, 2015, Highlights of PBTI Coimbra conference on PRT of plasma& current opinions on pathogen reduction treatment of blood components, Transfus Apher Sci, 52, 228, 10.1016/j.transci.2015.02.010 Seghatchian, 2015, Multilayer-strategy to enhance optimal safety of the blood supply: the role of pathogen inactivation for optimizing recipient safety and helping health care cost containment, Transfus Apher Sci, 52, 233, 10.1016/j.transci.2015.02.011 Seghatchian, 2015, Advances in transfusion science for shock-trauma: optimising the clinical management of acute haemorrhage, Transfus Apher Sci, 53, 412, 10.1016/j.transci.2015.11.012 Seghatchian, 2003, Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned, Transfus Apher Sci, 29, 105, 10.1016/S1473-0502(03)00112-5 Bianchi, 2015, Leucoreduction of blood components: an effective way to increase blood safety?, Blood Transfus Hervig, 2016, Leukocyte-reduced blood components: laboratory and clinical aspects Solheim, 2009, Pathogen inactivation, 801 D'Alessandro, 2016, Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology, Transfusion, 10.1111/trf.13483 Seghatchian, 1973, 747 Krailadsiri, 2006, The effect of leukodepletion on the generation and removal of microvesicles and prion protein in bleed components, Transfusion, 46, 407, 10.1111/j.1537-2995.2006.00737.x Garraud, 2016, Improving platelet transfusion safety: biomedical and technical considerations, Blood Transfus Yingdi, 2016, Sensitive and fast identification of bacteria in blood samples by immunoaffinity mass spectrometry for quick BSI diagnosis, Chem Sci, 7 D'Alessandro, 2015, An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies, Transfusion, 55, 205, 10.1111/trf.12804 Bruce, 2016, Unconventional cell death in erythroid cells, Blood, 127, 10.1182/blood-2015-11-677229 Laffont, 2016, Platelet micro-particles reprogram macrophage gene expression and function, Thromb Haemost, 115, 311, 10.1160/TH15-05-0389 Silliman, 2011, Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury, Transfusion, 51, 2549, 10.1111/j.1537-2995.2011.03186.x Dzieciatkowska, 2013, Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction, Vox Sang, 105, 210, 10.1111/vox.12042 Anniss, 2005, Proteomic analysis of supernatants of stored red blood cell products, Transfusion, 45, 1426, 10.1111/j.1537-2995.2005.00547.x Gyulkhandanyan, 2012, Markers of platelet apoptosis: methodology and applications, J Thromb Thrombolysis, 33, 397, 10.1007/s11239-012-0688-8 Loötvall, 2014, Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles, J Extracell Vesicles, 3, 26913, 10.3402/jev.v3.26913 Yáñez-Mo, 2015, Biological properties of extracellular vesicles and their physiological functions, J Extracell Vesicles, 4, 27066, 10.3402/jev.v4.27066 Kooijmans, 2016, Pegylated and targeted extracellular vesicles display enhanced cell specificity and circulation time, J Control Release, 10.1016/j.jconrel.2016.01.009 Flaumenhaft, 2008, Megakaryocyte-derived micro-particles: direct visualization and distinction from platelet-derived micro-particles, Blood, 113, 1112, 10.1182/blood-2008-06-163832